No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.
| Company | Type | Value | Reported | Company | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S— | Award | —9,160 shares | Sep 28, 2026 | Ascendis Pharma A/S | — | Award | 9,160 | Sep 28, 2026 |
| Ascendis Pharma A/S— | Returned to the issuer | —9,160 shares | Sep 28, 2026 | Ascendis Pharma A/S | — | Returned to the issuer | 9,160 | Sep 28, 2026 |
| Keros Therapeutics, Inc.— | Open-market buy | $10,2701,000 shares | Aug 19, 2026 | Keros Therapeutics, Inc. | $10,270 | Open-market buy | 1,000 | Aug 19, 2026 |
| Ascendis Pharma A/S— | Open-market buy | $222,219900 shares | Aug 18, 2026 | Ascendis Pharma A/S | $222,219 | Open-market buy | 900 | Aug 18, 2026 |
| Ascendis Pharma A/S— | Open-market buy | $270,4351,100 shares | Aug 18, 2026 | Ascendis Pharma A/S | $270,435 | Open-market buy | 1,100 | Aug 18, 2026 |